Argan Inc (AGX) stock
AGXNYSEConstruction - Special Trade ContractorsFiscal year ends January 31
Financials through Q2 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 2, 2026Score 21/3021% above fair value
$306.48−8.86 (-2.81%)
Close on Nov 13, 2026Market cap $4.30BP/E 24.2Yield 0.57%
Argan EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Argan's EPS for the twelve months ending Jul 31, 2026 was $12.64, up 51.9% year over year. For fiscal 2025 it was $9.74, up 58.4% from the year before. Over ten years it grew 14.9% a year on average. The highest annual figure on record is $9.74 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $9.74 | +58.4% |
| FY2024 | Jan 31, 2025 | $6.15 | +157.3% |
| FY2023 | Jan 31, 2024 | $2.39 | +2.6% |
| FY2022 | Jan 31, 2023 | $2.33 | -2.9% |
| FY2021 | Jan 31, 2022 | $2.40 | +58.9% |
| FY2020 | Jan 31, 2021 | $1.51 | – |
| FY2019 | Jan 31, 2020 | -$2.73 | -182.2% |
| FY2018 | Jan 31, 2019 | $3.32 | -27.2% |
| FY2017 | Jan 31, 2018 | $4.56 | +1.3% |
| FY2016 | Jan 31, 2017 | $4.50 | +86.0% |
| FY2015 | Jan 31, 2016 | $2.42 | +18.0% |
| FY2014 | Jan 31, 2015 | $2.05 | -26.3% |
| FY2013 | Jan 31, 2014 | $2.78 | +68.5% |
| FY2012 | Jan 31, 2013 | $1.65 | +146.3% |
| FY2011 | Jan 31, 2012 | $0.67 | +17.5% |
| FY2010 | Jan 31, 2011 | $0.57 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jul 31, 2026 | $3.76 | +50.4% |
| Q1 FY2026CQ1 2026 | Apr 30, 2026 | $3.24 | +102.5% |
| Q4 FY2025CQ4 2025 | Jan 31, 2026 | $3.47 | +56.3% |
| Q3 FY2025CQ3 2025 | Oct 31, 2025 | $2.17 | +8.5% |
| Q2 FY2025CQ2 2025 | Jul 31, 2025 | $2.50 | +90.8% |
| Q1 FY2025CQ1 2025 | Apr 30, 2025 | $1.60 | +175.9% |
| Q4 FY2024CQ4 2024 | Jan 31, 2025 | $2.22 | +149.4% |
| Q3 FY2024CQ3 2024 | Oct 31, 2024 | $2.00 | +400.0% |
| Q2 FY2024CQ2 2024 | Jul 31, 2024 | $1.31 | +39.4% |
| Q1 FY2024CQ1 2024 | Apr 30, 2024 | $0.58 | +262.5% |
| Q4 FY2023CQ4 2023 | Jan 31, 2024 | $0.89 | -11.0% |
| Q3 FY2023CQ3 2023 | Oct 31, 2023 | $0.40 | -28.6% |
| Q2 FY2023CQ2 2023 | Jul 31, 2023 | $0.94 | +213.3% |
| Q1 FY2023CQ1 2023 | Apr 30, 2023 | $0.16 | -68.0% |
| Q4 FY2022CQ4 2022 | Jan 31, 2023 | $1.00 | +614.3% |
| Q3 FY2022CQ3 2022 | Oct 31, 2022 | $0.56 | -28.2% |
| Q2 FY2022CQ2 2022 | Jul 31, 2022 | $0.30 | -63.0% |
| Q1 FY2022CQ1 2022 | Apr 30, 2022 | $0.50 | -25.4% |
| Q4 FY2021CQ4 2021 | Jan 31, 2022 | $0.14 | -76.7% |
| Q3 FY2021CQ3 2021 | Oct 31, 2021 | $0.78 | +30.0% |
| Q2 FY2021CQ2 2021 | Jul 31, 2021 | $0.81 | +125.0% |
| Q1 FY2021CQ1 2021 | Apr 30, 2021 | $0.67 | – |
| Q4 FY2020CQ4 2020 | Jan 31, 2021 | $0.60 | – |
| Q3 FY2020CQ3 2020 | Oct 31, 2020 | $0.60 | – |
| Q2 FY2020CQ2 2020 | Jul 31, 2020 | $0.36 | +414.3% |
| Q1 FY2020CQ1 2020 | Apr 30, 2020 | -$0.05 | – |
| Q4 FY2019CQ4 2019 | Jan 31, 2020 | -$0.46 | – |
| Q3 FY2019CQ3 2019 | Oct 31, 2019 | -$0.44 | -121.3% |
| Q2 FY2019CQ2 2019 | Jul 31, 2019 | $0.07 | -93.5% |
| Q1 FY2019CQ1 2019 | Apr 30, 2019 | -$1.91 | -716.1% |
| Q4 FY2018CQ4 2018 | Jan 31, 2019 | -$0.14 | -131.1% |
| Q3 FY2018CQ3 2018 | Oct 31, 2018 | $2.07 | +89.9% |
| Q2 FY2018CQ2 2018 | Jul 31, 2018 | $1.08 | -37.2% |
| Q1 FY2018CQ1 2018 | Apr 30, 2018 | $0.31 | -76.3% |
| Q4 FY2017CQ4 2017 | Jan 31, 2018 | $0.45 | -65.1% |
| Q3 FY2017CQ3 2017 | Oct 31, 2017 | $1.09 | -6.0% |
| Q2 FY2017CQ2 2017 | Jul 31, 2017 | $1.72 | – |
| Q1 FY2017CQ1 2017 | Apr 30, 2017 | $1.31 | – |
| Q4 FY2016CQ4 2016 | Jan 31, 2017 | $1.29 | – |
| Q3 FY2016CQ3 2016 | Oct 31, 2016 | $1.16 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?